Glucose-6-phosphate Reduces Fosfomycin Activity Against

Stenotrophomonas maltophilia adjuvant fosfomycin glucose-6-phosphate intrinsic resistance

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2022
Historique:
received: 27 01 2022
accepted: 29 03 2022
entrez: 27 5 2022
pubmed: 28 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

It is generally accepted that fosfomycin activity is higher in the presence of glucose-6-phosphate, since its inducible transporter UhpT is one of the gates for fosfomycin entry. Accordingly, fosfomycin susceptibility tests are performed in the presence of this sugar; however, since

Identifiants

pubmed: 35620111
doi: 10.3389/fmicb.2022.863635
pmc: PMC9127766
doi:

Types de publication

Journal Article

Langues

eng

Pagination

863635

Informations de copyright

Copyright © 2022 Gil-Gil and Martínez.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Mol Sci. 2021 Dec 23;23(1):
pubmed: 35008587
PLoS Genet. 2018 Oct 15;14(10):e1007727
pubmed: 30321174
Indian J Crit Care Med. 2018 Jul;22(7):533-536
pubmed: 30111930
Antimicrob Agents Chemother. 2011 Sep;55(9):4295-301
pubmed: 21670185
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
J Bacteriol. 1973 Nov;116(2):1079-81
pubmed: 4583235
mSystems. 2020 Jun 2;5(3):
pubmed: 32487742
J Infect Chemother. 2015 Feb;21(2):114-7
pubmed: 25456893
Int J Mol Sci. 2021 Jul 28;22(15):
pubmed: 34360847
Antimicrob Agents Chemother. 2015 Jul;59(7):4347-8
pubmed: 25918144
J Antimicrob Chemother. 1983 Jun;11(6):517-24
pubmed: 6885678
Appl Microbiol. 1969 Sep;18(3):469-73
pubmed: 4313764
Eur J Clin Microbiol. 1986 Feb;5(1):29-34
pubmed: 3084242
J Bacteriol. 2007 Nov;189(22):8079-87
pubmed: 17873029
Int J Mol Sci. 2022 Jan 20;23(3):
pubmed: 35163052
J Bacteriol. 2005 Aug;187(15):5267-77
pubmed: 16030221
Antimicrob Agents Chemother. 2000 Nov;44(11):3079-86
pubmed: 11036026
Antibiotics (Basel). 2020 Nov 12;9(11):
pubmed: 33198311
Infection. 1979;7(5):256-9
pubmed: 389806
J Clin Microbiol. 2020 Jan 28;58(2):
pubmed: 31748318
Environ Microbiol. 2014 May;16(5):1282-96
pubmed: 24447641
Clin Microbiol Rev. 2016 Apr;29(2):321-47
pubmed: 26960938
Front Microbiol. 2017 Aug 31;8:1511
pubmed: 28912755
Future Microbiol. 2009 Aug;4(6):655-60
pubmed: 19659422
Antimicrob Agents Chemother. 1991 Jun;35(6):1235-8
pubmed: 1929270
Microb Biotechnol. 2022 Feb;15(2):613-629
pubmed: 33960651
J Antimicrob Chemother. 2019 Nov 1;74(11):3221-3230
pubmed: 31369109
Antimicrob Agents Chemother. 2001 Jun;45(6):1879-81
pubmed: 11353642
Nat Rev Microbiol. 2015 Feb;13(2):116-23
pubmed: 25534811
Clin Microbiol Rev. 2012 Jan;25(1):2-41
pubmed: 22232370
Expert Rev Anti Infect Ther. 2020 Apr;18(4):335-347
pubmed: 32052662
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29581117
Clin Microbiol Infect. 2012 Jan;18(1):4-7
pubmed: 21914036
J Antibiot (Tokyo). 1975 Nov;28(11):906-11
pubmed: 1104551

Auteurs

Teresa Gil-Gil (T)

Centro Nacional de Biotecnología, CSIC, Madrid, Spain.
Programa de Doctorado en Biociencias Moleculares, Universidad Autónoma de Madri, Madrid, Spain.

José Luis Martínez (JL)

Centro Nacional de Biotecnología, CSIC, Madrid, Spain.

Classifications MeSH